CARTITUDE-10

Phase 2 Clinical Trial Further Evaluating the Safety and Efficacy of Ciltacabtagene-Autoleucel in Participants with Newly Diagnosed Multiple Myeloma in Whom an Autologous Bone Marrow Transplantation is Not Planned

Near Add Your Location

Sorting 5 by

UCSF Helen Diller Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA
  • Accepting patients
  • Show Principal Investigator
Cleveland Clinic - Taussig Cancer Center
Taussig Cancer Institute
Cleveland, OH
  • Accepting patients
  • Show Principal Investigator
Atrium Health's Levine Cancer Institute - Charlotte (Main)
Atrium Health
Charlotte, NC
  • Not yet accepting
  • Show Principal Investigator
The University of Texas Southwestern Medical Center
Harold C. Simmons Comprehensive Cancer Center
Dallas, TX
  • Not yet accepting
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.